论文部分内容阅读
对极重型ITP45例随机分为治疗组及对照组。治疗组25例,对照组20例,治疗组加用参麦注射液(2岁10ml,2～5岁20ml,5～9岁20～40ml)溶解于10％葡萄糖100～250ml中静滴,每日1次,10d为1疗程,并同时应用人血丙种球蛋白每天400mg/kg冲击治疗5d及地塞米松每天1.5～2mg/kg,对照组除未用参麦注射液静滴外,余同治疗组,结果两组间疗效有明显差异(P<0.O5),提示参麦注射液有一定的保护骨髓造血功能及明显的升血小板功能,能改善全身状况,增强疗效。
45 cases of very severe ITP were randomly divided into treatment group and control group. 25 cases in the treatment group and 20 cases in the control group. The patients in the treatment group were treated with Shenmai injection (2 ml 10 ml, 20 ml 2 ~ 5 years, 20 ~ 40 ml 5 ~ 9 years old) dissolved in 100 ~ 250 ml 10% glucose, Day 1, 10d for a course of treatment, and at the same time the application of human blood gamma globulin daily 400mg / kg impact treatment 5d and dexamethasone daily 1.5 ~ 2mg / kg, the control group except without Shenmai injection intravenously, Yu Tong Treatment group, the results between the two groups were significantly different (P <0.O5), suggesting that Shenmai injection has a certain degree of protection of bone marrow hematopoietic function and significant platelet function, can improve the general condition and enhance the efficacy.